| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.42 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |